ZANNETTI, ANTONELLA
 Distribuzione geografica
Continente #
AS - Asia 1.932
NA - Nord America 1.414
EU - Europa 603
SA - Sud America 404
Continente sconosciuto - Info sul continente non disponibili 122
AF - Africa 31
OC - Oceania 2
Totale 4.508
Nazione #
US - Stati Uniti d'America 1.337
SG - Singapore 798
CN - Cina 403
BR - Brasile 311
IT - Italia 244
VN - Vietnam 209
HK - Hong Kong 188
FR - Francia 109
BD - Bangladesh 90
NL - Olanda 74
KR - Corea 68
FI - Finlandia 45
JP - Giappone 43
IN - India 36
CA - Canada 30
GB - Regno Unito 30
DE - Germania 28
AR - Argentina 26
CO - Colombia 18
EC - Ecuador 16
MX - Messico 16
PL - Polonia 15
IL - Israele 12
CL - Cile 11
ES - Italia 11
UA - Ucraina 10
ID - Indonesia 9
VE - Venezuela 9
ZA - Sudafrica 9
IQ - Iraq 8
PK - Pakistan 8
UZ - Uzbekistan 8
CR - Costa Rica 7
PH - Filippine 7
SA - Arabia Saudita 7
PY - Paraguay 6
RU - Federazione Russa 6
TR - Turchia 6
LT - Lituania 5
EG - Egitto 4
LV - Lettonia 4
MA - Marocco 4
MY - Malesia 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
AZ - Azerbaigian 3
DZ - Algeria 3
IE - Irlanda 3
JM - Giamaica 3
KE - Kenya 3
MN - Mongolia 3
PE - Perù 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AU - Australia 2
BB - Barbados 2
BE - Belgio 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
GP - Guadalupe 2
HN - Honduras 2
HU - Ungheria 2
JO - Giordania 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
SE - Svezia 2
SI - Slovenia 2
TW - Taiwan 2
VC - Saint Vincent e Grenadine 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
IS - Islanda 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MG - Madagascar 1
MO - Macao, regione amministrativa speciale della Cina 1
MR - Mauritania 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SC - Seychelles 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
Totale 4.386
Città #
Singapore 494
Santa Clara 382
Hong Kong 186
San Jose 148
Hefei 146
Ashburn 106
Beijing 92
Lauterbourg 89
Ho Chi Minh City 73
Seoul 67
Los Angeles 65
Dallas 48
Naples 47
Hanoi 40
Tokyo 33
New York 25
Afragola 23
Chicago 23
Rome 21
São Paulo 21
Council Bluffs 20
Buffalo 17
Lappeenranta 17
Milan 17
Helsinki 14
Marigliano 14
Turku 13
Brooklyn 12
Rio de Janeiro 12
Belo Horizonte 11
Casandrino 10
Warsaw 10
Da Nang 9
Frankfurt am Main 9
Giugliano in Campania 9
Montreal 9
Falkenstein 8
Minamishinagawa 8
Tashkent 8
Bengaluru 7
Miami 7
Munich 7
Orem 7
Soccavo 7
Guayaquil 6
Phoenix 6
Boston 5
Curitiba 5
Denver 5
Dhaka 5
Fortaleza 5
Manchester 5
Ninh Bình 5
Queens 5
Quito 5
Riga 5
San José 5
Shanghai 5
Sorocaba 5
Thái Bình 5
Bari 4
Biên Hòa 4
Brasília 4
Can Tho 4
Chennai 4
Crowley 4
Ercolano 4
Guangzhou 4
Haiphong 4
London 4
Mexico City 4
Orlando 4
Paris 4
Porto Alegre 4
Santiago 4
Sarasota 4
Springfield 4
The Bronx 4
Turin 4
Amsterdam 3
Ankara 3
Atlanta 3
Baghdad 3
Baku 3
Bauru 3
Bloomfield 3
Campinas 3
Campos dos Goytacazes 3
Cape Town 3
Casablanca 3
Charlotte 3
Dongguan 3
Dublin 3
Duque de Caxias 3
Elk Grove Village 3
Fort Lauderdale 3
Fort Worth 3
Hamilton 3
Houston 3
Hyderabad 3
Totale 2.612
Nome #
Inhibition of carbonic anhydrases IX/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion 127
Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies 122
PET imaging of brain TSPO expression in a mouse model of Experimental Autoimmune Encephalomyelitis using [18F]DPA-714 103
Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells 94
In vivo imaging of CNS microglial activation/macrophage infiltration with combined [F-18]DPA-714-PET and SPIO-MRI in a mouse model of relapsing remitting experimental autoimmune encephalomyelitis 87
Therapeutic Potential of a Novel alpha(v)beta(3) Antagonist to Hamper the Aggressiveness of Mesenchymal Triple Negative Breast Cancer Sub-Type 83
Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors 83
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer 82
Optimization of Short RNA Aptamers for TNBC Cell Targeting 78
Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells 74
A Novel Inhibitor of Carbonic Anhydrases Prevents Hypoxia-Induced TNBC Cell Plasticity 74
The phosphatase Shp1 interacts with and dephosphorylates cortactin to inhibit invadopodia function 72
IN VITRO AND IN VIVO EVALUATION OF 111In-DTPAGlu-G-CCK8 FOR CHOLECYSTOKININ-B RECEPTOR IMAGING. 72
Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFR? Aptamer. Theranostics. 70
Gefitinib, a selective, tyrosine kinase inhibitor increases 99mTc-MIBI uptake in Bcl-2 overexpressing breast cancer cells. 68
Preclinical Imaging Evaluation of miRNAs' Delivery and Effects in Breast Cancer Mouse Models: A Systematic Review 64
Bone Marrow uptake of 99mTc-MIBI in patients with multiple myeloma 62
Inhibition of Bone Marrow-Mesenchymal Stem Cell-Induced Carbonic Anhydrase IX Potentiates Chemotherapy Efficacy in Triple-Negative Breast Cancer Cells 62
Expression of SARS-Cov-2 Entry Factors in Patients with Chronic Hepatitis 62
New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer 59
Lipid- and polymer-based formulations containing TNF-α inhibitors for the treatment of inflammatory bowel diseases 59
New and selective radiolabeled alpha(v)beta(3) antagonist as tracer in tumor diagnosis 58
Imaging of alpha(v)beta(3) integrin expression with a 18F-labeled RGD peptide and microPET 58
3'-deoxy-3'-18F-fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non-small cell lung cancer 58
Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells 57
In vivo imaging and characterization of [18F]DPA-714, a potential new TSPO ligand, in mouse brain and peripheral tissues using small-animal PET 56
Breast Cancer: From Pathophysiology to Novel Therapeutic Approaches 2.0 55
Editorial: Tumor Microenvironment: Molecular Mechanisms and Signaling Pathways Involved in Metastatic Progression 53
Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFR? Aptamer 51
Recruitment of stromal cells into tumour microenvironment promote the metastatic spread of breast cancer 51
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype 51
Aptamer-mediated impairment of EGFR-integrin alpha v beta 3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers 50
A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion 50
Recent Advances in Nuclear Imaging of Receptor Expression to Guide Targeted Therapies in Breast Cancer 50
Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRbeta aptamer 50
TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities 49
18F-FLT PET/CT to guide therapy with EGFR antagonists and Bcl-xL inhibitors in non-small cell lung cancer. 48
Autocrine signals increase ovine mesenchymal stem cells migration through Aquaporin-1 and CXCR4 overexpression 48
Molecular imaging of drug resistance in cancer 47
PET/CT in cancer research: from preclinical to clinical applications 45
In Vitro and In Vivo Evaluation of 111In- DTPAGlu-G-CCK8 for Cholecystokinin-B Receptor Imaging 45
Chemical Modification for Proteolytic Stabilization of the Selective alpha(v)beta(3) Integrin RGDechi Peptide: in Vitro and in Vivo Activities on Malignant Melanoma Cells 44
Inhibition of AQP1 Hampers Osteosarcoma and Hepatocellular Carcinoma Progression Mediated by Bone Marrow-Derived Mesenchymal Stem Cells 44
99mTc-MIBI in the evaluation of breast cancer biology 44
Dynamic coupling of 99mtc-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients 44
Effects of Thyroid Blockade on Brain Imaging of Dopamine Transporter in Normal Mice 43
Measurement of [123I]FP-CIT binding to the dopamine transporter (DAT) in healthy mouse striatum using dedicated small animal SPECT imaging: feasibility, optimization and validation. 43
inhibition of bone marrow-derived mesenchymal stem cells homing towards triple-negative breast cancer microenvironment using an anti-PDGFRbeta aptamer 42
IN VIVO IMAGING OF ALPHA(V)BETA(3) INTEGRIN EXPRESSION WITH A RADIOLABELED CHIMERIC RDG PEPTIDE 41
Role of Aquaporins in the Physiological Functions of Mesenchymal Stem Cells 41
Small animal SPECT with 99m-Tc-Hynic-annexin V for detection of non-small cell lung cancer resistance to EGFR antagonists and its reversal by Bcl-xL inhibitors 41
A novel CD44-targeting aptamer recognizes chemoresistant mesenchymal stem-like TNBC cells and inhibits tumor growth 40
Inhibition of Sp1 activity by a decoy PNA-DNA chimera prevents urokinase receptor expression and migration of breast cancer cells 39
Radiolabeling approaches for cholecystokinin B receptor imaging 38
Functional imaging of multidrug resistance in breast cancer 38
MIBI as prognostic factor in breast cancer. 37
Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma 36
18F-FLT PET/CT to guide therapy with EGFR antagonists and Bcl-xL inhibitors in non-small cell lung cancer 35
A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumors 35
Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myeloma 34
Nuclear imaging in cancer theranostics 34
99mTc-MIBI in the evaluation of breast cancer biology 34
Novel and selective αvβ3 receptor peptide antagonist: Design, synthesis, and biological behavior 34
High-Frequency Ultrasound-Guided Injection for the Generation of a Novel Orthotopic Mouse Model of Human Thyroid Carcinoma 34
AN IMPROVED RADIOLABELING SYNTHESIS OF RGDECHI WITH 18F-FLUORIDE. 33
In vivo imaging of alpha(v)beta(3) integrin expression with a radiolabeled chimeric RGD peptide 33
Imaging of alpha(v)beta(3) integrin expression with a 18F-labeled RGD peptide and microPET 33
MicroPET/CT of mice bearing alpha(v)beta(3)-expressing tumors by a 18F-labeled bifunctional chimeric RGD peptide 32
Gefitinib induction of in vivo detectable signals by Bcl-2/Bcl-X-L modulation of inositol trisphosphate receptor type 3 32
Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer 32
Inhibition of early 99mTc-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma. 31
Tumor-educated mesenchymal stem cells promote pro-metastatic phenotype 31
Combined Imaging with 18F-FLT PET/CT and 99m-Tc-Hynic-Annexin V SPECT for Personalized Therapy with EGFR Antagonists and Bcl-xL Inhibitors in Non-Small Cell Lung Cancer 31
A RADIOLABELING SYNTHESIS OF RGD ECHI WITH 18FLUORIDE- 31
Small animal SPECT with 99m-Tc-Hynic-annexin V for detection of non-small cell lung cancer resistance to EGFR antagonists and its reversal by Bcl-xL inhibitors 31
Stato dell'arte dell'imaging preclinico in oncologia 31
IMAGING IN VIVO DELL'ESPESSIONE DELL'INTEGRINA alfa(v)beta(3) CON UN PEPTIDE CHIMERICO RGD RADIOMARCATO 30
A New and selective radiolabeled alphavbeta3 peptide antagonist as tracer in tumor diagnosis 30
A NEW AND SELECTIVE RADIOLABELED ALPHAVBETA3 PEPTIDE ANTAGONIST AS TRACER IN TUMOR DIAGNOSIS. 30
Inhibition of early (99m)Tc-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma 29
Sphingosine kinase 1 overexpression contributes to cetuximab resistance in human colorectal cancer models 29
Novel and selective alpha(v)beta3 receptor peptide antagonist: design, synthesis, and biological behavior. 29
Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer 28
Novel and selective alpha v beta 3 receptor peptide antagonist: Design, synthesis and biological behaviour 28
A novel therapeutic approach targeting PD-L1 in HNSCC and bone marrow-derived mesenchymal stem cells hampers pro-metastatic features in vitro: perspectives for blocking tumor-stroma communication and signaling 27
Bcl-2 overexpression prevents 99mTc-MIBI uptake in breast cancer cell lines 27
In Vitro and In Vivo Evaluation of 111In- DTPAGlu-G-CCK8 for Cholecystokinin-B Receptor Imaging 26
PET/CT in cancer research: from preclinical to clinical applications 26
Coordinate upregulation of Sp1 DNA binding activity and urokinase receptor expression in breast carcinoma 25
New and selective radiolabeled alphavbeta3 peptide antagonist as tracer in tumor diagnosis 25
High Frequency Ultrasound for the development of an Orthotopic mouse model of Human Follicular Thyroid Carcinoma 25
Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRB aptamer 25
Molecular imaging of tumor microenvironment: challenges and perspectives 25
Elevated Expression of the Tyrosine Phosphatase SHP-1 Defines a Subset of High-Grade Breast Tumors 23
Urokinase Receptor Interacts with avb5 Vitronectin Receptor, Promoting Urokinase-dependent Cell Migration in Breast Cancer 19
Longitudinal evaluation with High Frequency Ultrasound imaging of response to CXCR4 new cyclic peptide antagonist with conventional chemotherapy in colorectal cancer mice model 18
A NEW AND SELECTIVE RADIOLABELLED v 3 PEPTIDE ANTAGONIST AS TRACER IN TUMOR DIAGNOSIS 17
Thermo-responsive in situ hydrogel enables superior rectal administration and local efficacy of 5-ASA in inflammatory bowel disease 4
Totale 4.508
Categoria #
all - tutte 15.330
article - articoli 13.387
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 263
Totale 28.980


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202443 0 0 0 0 0 0 0 0 1 5 22 15
2024/20251.626 26 13 165 57 368 77 40 70 85 93 338 294
2025/20262.386 106 280 188 320 414 102 368 97 147 144 137 83
2026/2027453 146 120 187 0 0 0 0 0 0 0 0 0
Totale 4.508